The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy.
Referral Center for Mixed Cryoglobulinemia, Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
Marcella
M
Visentini
Referral Center for Mixed Cryoglobulinemia, Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
Stefania
S
Colantuono
Referral Center for Mixed Cryoglobulinemia, Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
Guido
G
Granata
Division of Gastroenterology and Hepatology, Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
Adriano
A
de Santis
Referral Center for Mixed Cryoglobulinemia, Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
Massimo
M
Fiorilli
Referral Center for Mixed Cryoglobulinemia, Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
Milvia
M
Casato
D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D003362:Cost-Benefit Analysis; D003449:Cryoglobulinemia / Q000191:economics / Q000276:immunology / Q000628:therapy*; D005260:Female; D016174:Hepacivirus / Q000276:immunology*; D019698:Hepatitis C, Chronic / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D006760:Hospitalization / Q000191:economics; D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D015996:Survival Rate; D014657:Vasculitis / Q000191:economics / Q000276:immunology / Q000628:therapy*
D007372:Interferons